US20230390049A1 - Implant fabrication using three-dimensional woven fabric - Google Patents
Implant fabrication using three-dimensional woven fabric Download PDFInfo
- Publication number
- US20230390049A1 US20230390049A1 US18/448,035 US202318448035A US2023390049A1 US 20230390049 A1 US20230390049 A1 US 20230390049A1 US 202318448035 A US202318448035 A US 202318448035A US 2023390049 A1 US2023390049 A1 US 2023390049A1
- Authority
- US
- United States
- Prior art keywords
- woven fabric
- fibers
- docking device
- shape
- different types
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 239000002759 woven fabric Substances 0.000 title claims description 27
- 239000007943 implant Substances 0.000 title claims description 6
- 238000003032 molecular docking Methods 0.000 claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 55
- 239000000835 fiber Substances 0.000 claims abstract description 40
- 239000004753 textile Substances 0.000 claims abstract description 22
- 238000009941 weaving Methods 0.000 claims abstract description 20
- 238000002844 melting Methods 0.000 claims abstract description 19
- 230000008018 melting Effects 0.000 claims abstract description 15
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 239000011167 3D woven fabric Substances 0.000 claims description 60
- 239000000945 filler Substances 0.000 claims description 40
- 229920001169 thermoplastic Polymers 0.000 claims description 36
- 239000006260 foam Substances 0.000 claims description 33
- 239000011347 resin Substances 0.000 claims description 32
- 229920005992 thermoplastic resin Polymers 0.000 claims description 30
- 239000004744 fabric Substances 0.000 claims description 27
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 27
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 27
- 239000000560 biocompatible material Substances 0.000 claims description 23
- 210000003709 heart valve Anatomy 0.000 claims description 23
- 239000012781 shape memory material Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 18
- 239000004677 Nylon Substances 0.000 claims description 16
- 238000002513 implantation Methods 0.000 claims description 16
- 229920001778 nylon Polymers 0.000 claims description 16
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 14
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 10
- -1 polyethylene terephthalate Polymers 0.000 claims description 10
- 238000003825 pressing Methods 0.000 claims description 5
- 239000004416 thermosoftening plastic Substances 0.000 claims description 4
- 238000009958 sewing Methods 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 17
- 229910045601 alloy Inorganic materials 0.000 description 9
- 239000000956 alloy Substances 0.000 description 9
- 210000003484 anatomy Anatomy 0.000 description 9
- 230000008901 benefit Effects 0.000 description 7
- 239000002184 metal Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000003446 memory effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- KHYBPSFKEHXSLX-UHFFFAOYSA-N iminotitanium Chemical compound [Ti]=N KHYBPSFKEHXSLX-UHFFFAOYSA-N 0.000 description 4
- 229910001092 metal group alloy Inorganic materials 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000009954 braiding Methods 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 229920002529 medical grade silicone Polymers 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000000289 melt material Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 239000013514 silicone foam Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/20—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads
- D03D15/283—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the material of the fibres or filaments constituting the yarns or threads synthetic polymer-based, e.g. polyamide or polyester fibres
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D25/00—Woven fabrics not otherwise provided for
- D03D25/005—Three-dimensional woven fabrics
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D3/00—Woven fabrics characterised by their shape
- D03D3/02—Tubular fabrics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0071—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof thermoplastic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0043—L-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0065—Three-dimensional shapes toroidal, e.g. ring-shaped, doughnut-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
- A61F2240/004—Using a positive or negative model, e.g. moulds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0069—Sealing means
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
Definitions
- This invention relates generally to docking devices for bioprostheses, including implantable bioprosthetic heart valves.
- the present disclosure generally relates to docking devices for bioprostheses, such as bioprosthetic heart valves, and, more particularly, to docking devices that include a three-dimensional (3D) woven fabric, and methods of making such docking devices.
- bioprostheses such as bioprosthetic heart valves
- 3D three-dimensional
- the present disclosure relates to a docking device for a bioprosthesis comprising a 3D woven fabric forming a shaped element having an internal surface, an outer surface, and a thickness therebetween, and a filler structure coupled to the outer surface of the shaped element.
- the bioprosthesis can be a heart valve.
- the 3D woven fabric comprises first, second, and third different types of fibers or yarns.
- the first type of fiber or yarn can comprise a shape memory material
- the second type of fiber or yarn can comprise a low-melt thermoplastic polymer or resin
- the third type of fiber or yarn can comprise a high-tenacity biocompatible material.
- the shape memory material comprises Nitinol.
- the low-melt thermoplastic polymer or resin has a melting point between 85 degrees Celsius and 200 degrees Celsius.
- the low-melt thermoplastic polymer or resin can comprise Nylon.
- the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
- the filler structure can be covered with a material having low porosity and reduced permeability.
- the filler structure comprises polymer foam.
- the polymer foam can be at least partially covered with a tubular woven fabric.
- the tubular woven fabric comprises PET.
- the present disclosure relates to a 3D woven fabric for a bioprosthesis docking device comprising a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material.
- the shape memory material can comprise Nitinol.
- the low-melt thermoplastic polymer or resin has a melting point of 85 degrees Celsius to 200 degrees Celsius.
- the low-melt thermoplastic polymer or resin can comprise Nylon.
- the high-tenacity biocompatible material can comprise PET.
- the present disclosure relates to a method for making a docking device for a bioprosthesis.
- the method comprises weaving a 3D woven fabric by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material, and pressing and heating the 3D woven fabric over a shape-setting mold at temperatures greater than a melting point of the low-melt thermoplastic polymer or resin.
- the shape memory material comprises Nitinol
- the low-melt thermoplastic polymer or resin comprises Nylon having a melting point of 85 degrees Celsius to 200 degrees Celsius
- the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
- the method can further comprise attaching a filler structure to a surface of the 3D woven fabric.
- attaching the filler structure can comprise sewing the filler structure to the surface of the 3D woven fabric.
- the method can further comprise covering the filler structure with a tubular woven fabric comprising PET, wherein the filler comprises polymer foam.
- FIG. 1 is a perspective view of a docking device having three-dimensional (3D) woven fabric in accordance with one or more embodiments.
- FIG. 2 is a perspective view of the frame of an exemplary transcatheter heart valve deployed inside the docking device of FIG. 1 in accordance with one or more embodiments.
- FIGS. 3 A and 3 B are perspective views of the docking device of FIG. 1 , with a polymer foam coupled to an outer surface of the docking device and a tubular woven fabric covering the polymer foam in accordance with one or more embodiments.
- FIG. 4 is a cutaway perspective view of a tubular woven fabric covering a polymeric foam in accordance with one or more embodiments.
- FIG. 5 A is a cross-sectional schematic view of a 3D orthogonal woven unit cell in accordance with one or more embodiments.
- FIG. 5 B is a cross-sectional schematic view of a 3D multilayer woven unit cell in accordance with one or more embodiments.
- FIG. 5 C is a cross-sectional schematic view of a 3D angle-interlock woven unit cell in accordance with one or more embodiments.
- FIG. 6 is a perspective view of the docking device of FIG. 1 in a shape setting mandrel in accordance with one or more embodiments.
- Certain docking devices and methods utilize a woven or knitted fabric skirt material.
- textile skirts are made by using polyethylene terephthalate (PET) in both warp and weft directions.
- PET polyethylene terephthalate
- the PET material used may not have a shape memory effect that can change shape in connection with a trigger or stimulus, and may not be sufficiently elastic to provide for recovery after the deforming stress is removed. Therefore, it may be desirable to implement docking devices comprising fabrics and/or features that allow for improved flexibility with respect to shape or form.
- Some embodiments of docking devices disclosed herein are configured to adjust shape and/or form at least partially to the surrounding conditions/anatomy, and can take complex shapes to accommodate various different anatomies.
- the use of foam, polymer and/or biocompatible alloy with controlled diameter, size, and stiffness enables docking devices in accordance with the present disclosure to adjust and/or accommodate its shape or form to relatively complex anatomic geometries (e.g. different annulus sizes and/or shapes). That is, certain docking devices disclosed herein may be considered “universal” docking devices that provide desirable fit for a variety of sizes and/or shapes of patient anatomies.
- Universal docking devices may be desired for use with certain implantable medical devices.
- a universal docking device in accordance with the present disclosure may better conform to the complex anatomy associated with an implant site in some configurations.
- universal docking devices in accordance with one or more embodiments of the present disclosure may help prevent paravalvular leakage and/or eliminate the need to carefully size the existing heart valves.
- docking devices in accordance with one or more embodiments of the present disclosure can be configured to change shape and/or provide shape recovery after a deforming stress is removed, and can adjust to surrounding conditions to accommodate different complex anatomic geometries. Such attributes and/or characteristics can serve to at least partially mitigates paravalvular leakage.
- Some embodiments disclosed herein provide a device that is configured and/or designed to improve the fit of an implantable bioprosthetic heart valve within a native valve annulus, which can advantageously at least partially mitigate issues associated with valve sizing and/or paravalvular leakage.
- the unique and/or irregular size and/or surface characteristics of native valve annuli can present challenges to providing an implantable bioprosthetic heart valve that fits within, and is provided in intimate contact or seal with, the valve annulus.
- some embodiments disclosed herein advantageously provide a tubular or cylindrically-shaped device that is radially compressible for delivery and implantation in the native valve annulus before implantation of a bioprosthetic valve.
- the structure of tubular or cylindrically-shaped devices in accordance with the present disclosure can comprise both an inner three-dimensional (3D) woven fabric and an outer covering of polymeric foam.
- the 3D woven fabric can comprise three different fibers and/or yarns having different material properties.
- Different types of fibers and/or yarns that may be used can include shape memory material, such as Nitinol, low-melt thermoplastic polymer or resin having a melting point in the range of about 166-175° C., such as Nylon, and high-tenacity biocompatible material, such as PET.
- the polymeric foam can be attached to the outer surface of the 3D woven fabric and can provide a compressible seal with the native annulus.
- docking devices in accordance with the present disclosure can be manufactured to the desired shape at least in part by pressing and/or heating the 3D woven fabric over a shape-setting mold at temperatures above the melting point of the low-melt thermoplastic polymer or resin.
- the melting of low-melt material can function as an adhesive to set the shape of the fabric.
- a foam material can be attached or sewed onto the 3-D woven fabric.
- the present disclosure provides a method for fabricating a universal docking device, wherein a main body of the docking device is made of shape memory material (e.g., Ni—Ti alloy, Nitinol) and thermoplastic fibers by utilizing 3D weaving techniques.
- shape memory material e.g., Ni—Ti alloy, Nitinol
- thermoplastic fibers by utilizing 3D weaving techniques.
- Such 3D weaving techniques may be implemented on a specialized 3D weaving machine.
- three sets of yarns are used to interlace with each other, as compared to two sets of yarn in flat-woven structures.
- the weave can be orthogonal or multilayer, and multiple layers can be woven together to form a 3D fabric.
- memory metal e.g., Ni—Ti
- low-melt Nylon In the width-wise (i.e., “filling” or “weft”) direction, memory metal (e.g., Ni—Ti) round wire and low-melt Nylon can be used apart from high tenacity polyethylene terephthalate (PET).
- PET polyethylene terephthalate
- the melting temperature of the low-melt nylon resin can be designed to be in range of 166-175° C.
- methods of fabricating a docking device in accordance with one or more embodiments of the present disclosure can involve pressing the fabric over a shape-setting mold (e.g., having a specific custom shape) and heated for a period of time (e.g., 30-60 min) at temperatures higher than the melting point of the low-melt Nylon resin, thereby causing the low-melt nylon to melt.
- the melted Nylon can act as an adhesive, and can at least partially set the shape of the fabric.
- the method may further involve leaving the shape-set fabric on the mold to cool-off for a period of time (e.g., 1 hour), and then removing the shape-set fabric and covering the same with a tubular woven fabric filled with foam or other at least partially compressible material (e.g., polymer, biocompatible alloy, etc.).
- foam or other at least partially compressible material e.g., polymer, biocompatible alloy, etc.
- foam, polymer or biocompatible alloy outside the device can advantageously help reduce paravalvular leakage as such material can be compressed during delivery to the annulus, and once deployment is complete, the material can at least partially decompress and form an improved seal.
- the use of tubular textile around the form or other compressible material can help control the porosity of such materials, as foam or polymeric materials can be undesirably porous; the outside textile (e.g., PET) covering can reduce permeability.
- the docking device 100 includes a three-dimensional (3D) woven fabric 10 forming an internal surface 5 , an outer surface 35 , and having a thickness therebetween provided by the 3D nature of the fabric 10 .
- the 3D woven fabric can form a substantially hollow cylinder 30 having an outer surface 35 and inner surface 5 .
- the 3D woven fabric can form a ring, or ring-type form or structure. Other shapes are also possible, depending on the bioprosthetic device being docked within, or on, the docking device 100 .
- the docking device 100 can be interposed between an implantable heart valve and a native valve annulus to provide an improved conforming fit and/or to reduce the likelihood and/or degree of a paravalvular leakage.
- the 3D woven fabric 10 can be a hybrid fabric comprising polyethylene terephthalate (PET), memory metal (e.g., Ni—Ti alloy, Nitinol), and low-melt Nylon alloy, and can be made using any suitable or desirable weaving technique or configuration/arrangement.
- PET polyethylene terephthalate
- memory metal e.g., Ni—Ti alloy, Nitinol
- low-melt Nylon alloy e.g., Ni—Ti alloy, Nitinol
- memory metal e.g., Ni—Ti alloy, Nitinol
- the woven fabric structure 10 can be woven in 2D, 3D, and can be configured to fit any anatomical structure, by using the shape memory effect, or super elastic effect, of the memory metal wire or other material of the fabric.
- the woven fabric 10 can be configured to fit any desirable human anatomical part(s) through the use of shape memory alloy to change the shape of the mold.
- the fabric 10 can also be used in sheet form as a scaffold for tissue engineering with shape memory effect customized to any human anatomical shape.
- the docking device 100 can be compressed and delivered, such as through a catheter, to the implantation site.
- the docking device 100 can be expanded to fit, and be held at, the local anatomy (e.g., the native heart valve annulus) associated with the implantation site.
- the docking device 100 can then act as a landing site for a bioprosthesis 200 , such as a transcatheter heart valve.
- FIG. 2 illustrates a perspective view of a frame 200 of an exemplary transcatheter heart valve deployed inside the docking device of FIG. 1 in accordance with one or more embodiments.
- the docking device 100 can be interposed between a bioprosthesis 200 , such as a transcatheter heart valve (THV), and native tissue, such as a native valve annulus (not shown).
- THV transcatheter heart valve
- FIG. 2 only shows the frame of an exemplary transcatheter heart valve 200 within the docking device 100 , it should be understood that, in some implementations, other devices besides a THV can benefit from implantation within the docking device 200 and/or other docking devices in accordance with embodiments of the present disclosure.
- the docking device 100 can be configured or designed to be implanted at any suitable or desirable implantation site. However, implantation sites of different patients can present relative irregularity of shapes across patients. By using shape memory effect for the fabric 10 , the docking device 100 can be used to fit into irregular shapes.
- the device 100 can be configured to be compressed and delivered through a catheter to the implant site. At the delivery site, depending on whether using super-elastic shape memory metal or polymer is used, the device 100 can expand by itself or through temperature stimulus to fit the size of the implantation site anatomy (e.g., heart valve annulus). Foam or other compressible material (not shown in FIGS.
- the docking device 100 can act as a landing site for the prosthetic heart valve.
- FIGS. 3 A and 3 B are perspective views of the docking device 100 of FIG. 1 , wherein the docking device 100 has a polymer foam 40 coupled to an outer surface 35 of the docking device 100 and a tubular woven fabric 45 covering the polymer foam 40 in accordance with one or more embodiments.
- the docking device 100 can further include a filler 40 (also referred to herein as a “filler structure”) coupled to the outer surface 35 of the hollow cylinder 30 .
- the filler 40 can comprise a polymeric foam.
- the polymeric foam can be an open-celled foam or a closed-cell foam.
- the filler 40 form or structure can be provided to partially or completely surround a circumference of the outer surface 35 of the hollow cylinder 30 .
- the filler 40 can include a compressible or expandable material that can fill a desired space.
- the filler 40 can be or comprise a polymer foam.
- the filler 40 can comprise medical-grade silicone and/or a biocompatible alloy.
- the filler can comprise one or more of polymeric foam, polyurethane foam, polyvinyl chloride foam, Styrofoam, polyimide foam, silicone foam, and/or microcellular foam.
- the filler structure 40 can be configured to be compressed during delivery of the docking device 100 to the implantation site (e.g., valve annulus). Once deployed, the filler 40 can be configured to decompress to provide a compressible seal against the surrounding native tissue.
- This compressible seal can be optimized by varying the shape, size, and stiffness of the filler 40 .
- the filler 40 can be configured, as shown in FIG. 3 A , to cover a portion of the outer surface 35 of the hollow cylinder 30 .
- the filler can be configured, as shown in FIG. 3 B , to cover substantially all, or at least a majority, of the outer surface 35 . In this way, the configuration of the filler can be optimized to enable the docking device 100 to accommodate itself to complex anatomic geometries and/or, in the case of a prosthetic heart valve, to reduce paravalvular leakage.
- the filler 40 can be dimensioned to cover at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or 100% of the outer surface 35 of the hollow cylinder 30 . In some embodiments, the filler can also be dimensioned to cover a percentage of the outer surface that includes and is between any two of the foregoing values.
- FIG. 4 is a cutaway perspective view of a tubular woven fabric 45 covering a polymeric foam 40 in accordance with one or more embodiments.
- the filler component/structure of a docking device in accordance with aspects of the present disclosure comprises a material that is, by itself, too porous to fully prevent or mitigate paravalvular leakage.
- the filler 40 can be covered with a tubular woven fabric 45 , such as PET.
- the filler 40 can be secured to a docking device, such as the docking device 100 shown in FIGS. 3 A and 3 B , by attaching the tubular woven fabric 45 to the outer surface 35 of the docking device's hollow cylinder 30 .
- the tubular woven fabric 45 may be attached to the outer surface 35 by adhering or suturing the tubular woven fabric 45 directly to the outer surface 35 . So configured, the tubular woven fabric with its low porosity and reduced permeability, can further mitigate paravalvular leakage.
- the tubular woven fabric 45 can also be provided to protect or ensure against the release of any undesired particulate matter from the filler 40 , particularly with respect to embodiments in which the filler 40 is made of a porous and/or a foam material. Such particulate matter can be released due to the frictional forces imposed on the filler 40 during the delivery and/or implantation process(es). Release of such particulate matter can be undesirable as presenting a higher risk of embolization.
- the present disclosure is related to relatively complex textile structures generated by utilizing weaving, braiding, knitting and/or a combination thereof.
- Such textiles structures can be generated using shape memory fibers or alloys (e.g., Nitinol) in combination with one or more thermoplastic textile fibers, such as Nylon, polyethylene terephthalate (PET), polypropylene (PP), and/or polybutylene terephthalate (PBT).
- shape memory fibers or alloys e.g., Nitinol
- thermoplastic textile fibers such as Nylon, polyethylene terephthalate (PET), polypropylene (PP), and/or polybutylene terephthalate (PBT).
- Hybrid textile structures in accordance with the present disclosure can be created using a base substrate fabric, and using electro-spinning to lay shape memory fibers on top of the substrate fabric, or by wrapping a low-melt Nylon in a core-sheath structure.
- the textile structure can be formed into a hollow cylinder
- Devices in accordance with some implementations can include a three-dimensional (3D) woven fabric that is formed into a hollow cylinder, as well as a polymer foam attached to the hollow cylinder.
- the 3D woven fabric can advantageously comprise three different types of yarns or fibers, as described in detail herein.
- the 3D woven fabric can comprise one or more of the following types of yarns and/or fibers: shape memory material, low-melt thermoplastic polymer or resin, and high-tenacity biocompatible material.
- 3D woven fabrics in accordance with embodiments of the present disclosure can comprise three different types of fibers or yarns.
- the three different types of fibers or yarns can comprise a combination of a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material.
- the shape memory material can be or comprise a metal alloy.
- the metal alloy can comprise nickel and/or titanium, such as Nitinol.
- the shape memory material can provide the desired shape and geometry of the device.
- the low-melt thermoplastic polymer or resin material in some embodiments, such material can act as a binder or glue to fuse woven layers of the 3D fabric 10 together and conform the 3D woven fabric 10 to a desired shape.
- the low-melt thermoplastic polymer or resin can be or comprise Nylon, for example.
- the low-melt thermoplastic polymer or resin can have a relatively low-melting point.
- the low-melting point of the low-melt thermoplastic polymer or resin can be 200o C or less, 195° C. or less, 190° C. or less, 185° C. or less, 180° C. or less, 175° C. or less, 170° C. or less, 165° C. or less, 160° C. or less, 155° C. or less, 150° C. or less, 145° C. or less, 140° C. or less, 135° C. or less, 130° C. or less, 125° C. or less, 120° C. or less, 115° C. or less, 110° C. or less, 105° C. or less, and 100° C. or less.
- the low-melting point can be within a range that includes and is between any two of the foregoing values.
- the high-tenacity biocompatible material can improve the durability of the 3D woven fabric 10 and promote tissue growth.
- the high-tenacity biocompatible material can have a tenacity, or breaking load, of about 5 grams per Denier or more, about 6 grams per Denier or more, about 7 grams per Denier or more, about 8 grams per Denier or more, about 9 grams per Denier or more, about 10 grams per Denier or more, about 11 grams per Denier or more, about 12 grams per Denier or more, about 13 grams per Denier or more, about 14 grams per Denier or more, or about 15 grams per Denier.
- the breaking load can also be within a range that includes and/or is between any two of the foregoing values.
- the high-tenacity biocompatible material can be PET.
- a docking device 100 for a bioprosthesis 200 comprises weaving a 3D woven fabric 10 by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material.
- the shape memory material can be a metal alloy.
- the metal alloy can comprise nickel and titanium, such as Nitinol.
- the low-melt thermoplastic polymer or resin can be a polymer having a low-melting point.
- the polymer can be nylon.
- the high-tenacity biocompatible material can be PET.
- 3D woven fabrics can generally be woven by manipulating yarns in the length (“warp,” or “ends”), width (“weft,” “filling,” or “picks”), and through-the-thickness directions.
- the combination of the low-melt thermoplastic polymer and the 3D weave pattern can allow the thickness of the 3D woven fabric to be varied based on the number of layers of the weft and warp yarns.
- the thickness of the 3D woven fabric can be increased by increasing the number of layers of the weft and warp yarns with the low-melt thermoplastic polymer and the through-the-thickness yarns binding the plurality of layers together.
- the through-the-thickness yarn can be incorporated at varying levels and angles within orthogonal ( FIG. 5 A ), multilayer ( FIG. 5 B ), and angle-interlock ( FIG. 5 C ) woven structures to obtain desired mechanical properties.
- the weaving step can be performed on conventional weaving machines or specially-made weaving machines.
- braiding or knitting techniques can be employed to manufacture the 3D fabric. However, in some implementations, such methods may not produce sufficient thickness.
- the 3D woven fabric 10 can comprise an orthogonal weave structure.
- Orthogonal weave structures can include a set of warp yarns 15 , a set of filling yarns 20 , and a set of through-the-thickness yarns 25 .
- Warp yarns 15 can be placed in the fabric length direction and filling yarns 20 can be inserted between the length layers to form double picks.
- Through-the-thickness yarns 25 can interconnect the other two yarn sets and provide structural integrity.
- the thickness of the orthogonal structure can be formed by the number of layers of the warp or weft yarn.
- yarns are substantially straight in the warp, weft, and through-the-thickness directions.
- the through-the-thickness yarns can generally travel vertically between the top and bottom weft yarn layers, and can also interlink with weft yarn layers at other levels in some embodiments.
- the 3D woven fabric 10 can comprise an orthogonal weave structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of filling yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of through-the-thickness yarns 25 can comprise a high-tenacity biocompatible material.
- the 3D woven fabric 10 can comprise an orthogonal weave structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of filling yarns 20 can comprise a shape memory material, and the set of through-the-thickness yarns 25 can comprise a low-melt thermoplastic polymer or resin.
- the 3D woven fabric 10 can comprise a multilayer weave structure.
- Multilayer weave structures can include a set of warp yarns 15 , a set of weft yarns 20 , and a set of through-the-thickness binding yarns 25 .
- Warp yarns 15 can be interlaced with weft yarns 20 at each layer according to the weave pattern in in-plane principal directions, whereas binding yarns 25 can be interlaced with warp yarns 15 at each layer according to the weave pattern in out-of-plane principal directions.
- the multilayer weave structure can be fully interlaced or semi-interlaced.
- the 3D woven fabric 10 can comprise a multilayer weave structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of weft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of binding yarns 25 can comprise a high-tenacity biocompatible material.
- the 3D woven fabric 10 can comprise a multilayer weave structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of weft yarns 20 can comprise a shape memory material, and the set of binding yarns 25 can comprise a low-melt thermoplastic polymer or resin.
- the 3D woven fabric 10 comprises an angle-interlock weave structure.
- Angle-interlock weave structures in accordance with the present disclosure can include a set of warp yarns 15 , a set of straight weft yarns 20 (wadding), and a set of bias weft yarns 25 that weave with the warp yarns 15 in a diagonal direction in the thickness.
- bias weft yarns 25 can travel between two or more successive layers making interlacements with several wadding yarns 20 according to the weave pattern.
- bias weft yarns 25 can bind diagonally from the top layer to the bottom layer.
- the 3D woven fabric 10 can comprise an angle-interlock structure, wherein the set of warp yarns 15 can comprise a shape memory material, the set of straight weft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of bias weft yarns 25 can comprise a high-tenacity biocompatible material.
- the 3D woven fabric 10 can comprise an angle-interlock structure, wherein the set of warp yarns 15 can comprise a high-tenacity biocompatible material, the set of straight weft yarns 20 can comprise a shape memory material, and the set of bias weft yarns 25 can comprise a low-melt thermoplastic polymer or resin.
- the 3D woven fabric 10 can be manufactured using any of the different varieties of 3D weave structures.
- the docking device 100 may be subjected to compressive forces between the bioprosthesis 200 and the surrounding native valve tissue.
- the compressibility of the docking device 100 can be, in part, a function of the compressibility of the 3D woven fabric, which can, in turn, be a function of the fabric's weave structure, fabric density, and/or other characteristics of the constituent fibers/yarns. Accordingly, the 3D woven fabric's 10 weave structure and fabric density can be selected to optimize the compressibility of docking device 100 .
- Fabric density can be quantified by ends-per-inch (EPI) and/or picks-per-inch (PPI).
- the 3D woven fabric 10 can have about 115 EPI, about 120 EPI, about 125 EPI, about 130 EPI, about 135 EPI, about 140 EPI, about 145 EPI, about 150 EPI, about 155 EPI, about 160 EPI, about 165 EPI, about 170 EPI, about 175 EPI, about 180 EPI, about 185 EPI, about 190 EPI, about 195 EPI, about 200 EPI, about 205 EPI, about 210 EPI, about 215 EPI, about 220 EPI, about 225 EPI, about 230 EPI, about 235 EPI, about 240 EPI, about 245 EPI, about 250 EPI, about 255 EPI, about 260 EPI, about 265 EPI, about 270 EPI, about 275 EPI, about 280 EPI, about 285 EPI, about 290 EPI, about 295 E
- the 3D woven fabric 10 can have about 115 PPI, about 120 PPI, about 125 PPI, about 130 PPI, about 135 PPI, about 140 PPI, about 145 PPI, about 150 PPI, about 155 PPI, about 160 PPI, about 165 PPI, about 170 PPI, about 175 PPI, about 180 PPI, about 185 PPI, about 190 PPI, about 195 PPI, about 200 PPI, about 205 PPI, about 210 PPI, about 215 PPI, about 220 PPI, about 225 PPI, about 230 PPI, about 235 PPI, about 240 PPI, about 245 PPI, about 250 PPI, about 255 PPI, about 260 PPI, about 265 PPI, about 270 PPI, about 275 PPI, about 280 PPI, about 285 PPI, about 290 PPI, about 295 PPI, about 300 PPI, about 305 PPI, about 310 PPI, or about 315 PPI, about 320 P
- the docking device 100 exhibits a compressibility of no more than 5%, no more than 10%, no more than 15%, no more than 20%, no more than 25%, no more than 30%, no more than 35%, no more than 40%, no more than 45%, no more than 50%, no more than 55%, no more than 60%, no more than 65%, or no more than 70% across its thickness.
- the docking device can exhibit a compressibility of between and including any two of the foregoing values.
- a method for making a docking device 100 for a bioprosthesis can comprise the step of pressing and heating the 3D woven fabric 10 over a shape-setting mold 50 at temperatures greater than the melting point of the low-melt thermoplastic polymer or resin. This step can melt the low-melt thermoplastic polymer or resin yarn, which can function as an adhesive to set the shape of the 3D woven fabric 10 as desired.
- the 3D woven fabric 10 can be heated on the shape-setting mold 50 from about 30 minutes to about 60 minutes.
- the bioprosthesis can be a transcatheter heart valve, and the 3D woven fabric 10 can be molded accordingly. It should be understood, however, that the 3D woven fabric 10 can be molded to accommodate other bioprostheses, or as a scaffold for tissue engineering.
- the method can further comprise the step of attaching a filler 40 to a surface 35 of the 3D woven fabric 10 , for example by sewing the filler 40 to the surface 35 of the 3D woven fabric 10 .
- the method can include the step of covering the filler 40 with a tubular woven fabric 45 comprising, for example, polyethylene terephthalate (PET).
- PET polyethylene terephthalate
- the filler 40 can be a polymer foam.
- the present invention provides a universal docking device that can be radially compressible, for delivery and implantation, and that changes shape and recovers after a deforming stress is removed.
- the docking device adjusts to surrounding conditions to accommodate different complex anatomic geometries, and provides conforming support while minimizing or eliminating leakage around the implanted device.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Textile Engineering (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A method of fabricating a docking device involves implementing a three-dimensional (3D) weaving technique to form a 3D textile structure using a plurality of different types of fibers, heating the 3D textile structure on a shape-setting mold at a temperature above a melting point of a first type of fiber of the plurality of different types of fibers to set a cylindrical shape of the 3D textile structure, maintaining the 3D textile structure on the shape-setting mold to cool off for a period of time, and removing the 3D textile structure from the shape-setting mold.
Description
- This application is a divisional of U.S. patent application Ser. No. 17/071,641, filed on Oct. 15, 2020 and entitled THREE-DIMENSIONAL WOVEN FABRIC IMPLANT DEVICES, which is a continuation of U.S. patent application Ser. No. 15/841,046, filed on Dec. 13, 2017 and entitled DOCKING DEVICE MADE WITH 3D WOVEN FABRIC, which claims priority to U.S. Provisional Application No. 62/436,866, filed on Dec. 20, 2016 and entitled DOCKING DEVICE MADE WITH 3D WOVEN FABRIC, the disclosures of which are hereby incorporated by reference in their entirety.
- This invention relates generally to docking devices for bioprostheses, including implantable bioprosthetic heart valves.
- The unique geometry and sometimes irregular size of a patient's native heart valve anatomy present challenges to providing an implantable bioprosthetic heart valve that fits within and is provided in intimate contact or seal with the surrounding tissue.
- The present disclosure generally relates to docking devices for bioprostheses, such as bioprosthetic heart valves, and, more particularly, to docking devices that include a three-dimensional (3D) woven fabric, and methods of making such docking devices.
- In some implementations, the present disclosure relates to a docking device for a bioprosthesis comprising a 3D woven fabric forming a shaped element having an internal surface, an outer surface, and a thickness therebetween, and a filler structure coupled to the outer surface of the shaped element. The bioprosthesis can be a heart valve.
- In certain embodiments, the 3D woven fabric comprises first, second, and third different types of fibers or yarns. For example, the first type of fiber or yarn can comprise a shape memory material, the second type of fiber or yarn can comprise a low-melt thermoplastic polymer or resin, and the third type of fiber or yarn can comprise a high-tenacity biocompatible material. In certain embodiments, the shape memory material comprises Nitinol. In certain embodiments, the low-melt thermoplastic polymer or resin has a melting point between 85 degrees Celsius and 200 degrees Celsius. For example, the low-melt thermoplastic polymer or resin can comprise Nylon. In certain embodiments, the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
- The filler structure can be covered with a material having low porosity and reduced permeability. In certain embodiments, the filler structure comprises polymer foam. For example, the polymer foam can be at least partially covered with a tubular woven fabric. In certain embodiments, the tubular woven fabric comprises PET.
- In some implementations, the present disclosure relates to a 3D woven fabric for a bioprosthesis docking device comprising a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. The shape memory material can comprise Nitinol. In certain embodiments, the low-melt thermoplastic polymer or resin has a melting point of 85 degrees Celsius to 200 degrees Celsius. The low-melt thermoplastic polymer or resin can comprise Nylon. The high-tenacity biocompatible material can comprise PET.
- In some implementations, the present disclosure relates to a method for making a docking device for a bioprosthesis. The method comprises weaving a 3D woven fabric by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material, and pressing and heating the 3D woven fabric over a shape-setting mold at temperatures greater than a melting point of the low-melt thermoplastic polymer or resin. In certain embodiments, the shape memory material comprises Nitinol, the low-melt thermoplastic polymer or resin comprises Nylon having a melting point of 85 degrees Celsius to 200 degrees Celsius, and the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
- The method can further comprise attaching a filler structure to a surface of the 3D woven fabric. For example, attaching the filler structure can comprise sewing the filler structure to the surface of the 3D woven fabric. The method can further comprise covering the filler structure with a tubular woven fabric comprising PET, wherein the filler comprises polymer foam.
- Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the inventions. In addition, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure. Throughout the drawings, reference numbers may be reused to indicate correspondence between reference elements.
-
FIG. 1 is a perspective view of a docking device having three-dimensional (3D) woven fabric in accordance with one or more embodiments. -
FIG. 2 is a perspective view of the frame of an exemplary transcatheter heart valve deployed inside the docking device ofFIG. 1 in accordance with one or more embodiments. -
FIGS. 3A and 3B are perspective views of the docking device ofFIG. 1 , with a polymer foam coupled to an outer surface of the docking device and a tubular woven fabric covering the polymer foam in accordance with one or more embodiments. -
FIG. 4 is a cutaway perspective view of a tubular woven fabric covering a polymeric foam in accordance with one or more embodiments. -
FIG. 5A is a cross-sectional schematic view of a 3D orthogonal woven unit cell in accordance with one or more embodiments. -
FIG. 5B is a cross-sectional schematic view of a 3D multilayer woven unit cell in accordance with one or more embodiments. -
FIG. 5C is a cross-sectional schematic view of a 3D angle-interlock woven unit cell in accordance with one or more embodiments. -
FIG. 6 is a perspective view of the docking device ofFIG. 1 in a shape setting mandrel in accordance with one or more embodiments. - The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claimed invention.
- Although certain preferred embodiments and examples are disclosed below, inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and to modifications and equivalents thereof. Thus, the scope of the claims that may arise herefrom is not limited by any of the particular embodiments described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence. Various operations may be described as multiple discrete operations in turn, in a manner that may be helpful in understanding some embodiments; however, the order of description should not be construed to imply that these operations are order dependent. Additionally, the structures, systems, and/or devices described herein may be embodied as integrated components or as separate components. For purposes of comparing various embodiments, certain aspects and advantages of these embodiments are described. Not necessarily all such aspects or advantages are achieved by any particular embodiment. Thus, for example, various embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may also be taught or suggested herein.
- Certain docking devices and methods utilize a woven or knitted fabric skirt material. In some implementations, textile skirts are made by using polyethylene terephthalate (PET) in both warp and weft directions. However, generally, the PET material used may not have a shape memory effect that can change shape in connection with a trigger or stimulus, and may not be sufficiently elastic to provide for recovery after the deforming stress is removed. Therefore, it may be desirable to implement docking devices comprising fabrics and/or features that allow for improved flexibility with respect to shape or form. Some embodiments of docking devices disclosed herein are configured to adjust shape and/or form at least partially to the surrounding conditions/anatomy, and can take complex shapes to accommodate various different anatomies. In some implementations, the use of foam, polymer and/or biocompatible alloy with controlled diameter, size, and stiffness enables docking devices in accordance with the present disclosure to adjust and/or accommodate its shape or form to relatively complex anatomic geometries (e.g. different annulus sizes and/or shapes). That is, certain docking devices disclosed herein may be considered “universal” docking devices that provide desirable fit for a variety of sizes and/or shapes of patient anatomies.
- Universal docking devices may be desired for use with certain implantable medical devices. For example, a universal docking device in accordance with the present disclosure may better conform to the complex anatomy associated with an implant site in some configurations. Furthermore, particularly with respect to bioprosthetic heart valves, universal docking devices in accordance with one or more embodiments of the present disclosure may help prevent paravalvular leakage and/or eliminate the need to carefully size the existing heart valves. With respect to these benefits, docking devices in accordance with one or more embodiments of the present disclosure can be configured to change shape and/or provide shape recovery after a deforming stress is removed, and can adjust to surrounding conditions to accommodate different complex anatomic geometries. Such attributes and/or characteristics can serve to at least partially mitigates paravalvular leakage.
- Some embodiments disclosed herein provide a device that is configured and/or designed to improve the fit of an implantable bioprosthetic heart valve within a native valve annulus, which can advantageously at least partially mitigate issues associated with valve sizing and/or paravalvular leakage. For example, generally, the unique and/or irregular size and/or surface characteristics of native valve annuli can present challenges to providing an implantable bioprosthetic heart valve that fits within, and is provided in intimate contact or seal with, the valve annulus. To address such challenges, some embodiments disclosed herein advantageously provide a tubular or cylindrically-shaped device that is radially compressible for delivery and implantation in the native valve annulus before implantation of a bioprosthetic valve.
- The structure of tubular or cylindrically-shaped devices in accordance with the present disclosure can comprise both an inner three-dimensional (3D) woven fabric and an outer covering of polymeric foam. For example, the 3D woven fabric can comprise three different fibers and/or yarns having different material properties. Different types of fibers and/or yarns that may be used can include shape memory material, such as Nitinol, low-melt thermoplastic polymer or resin having a melting point in the range of about 166-175° C., such as Nylon, and high-tenacity biocompatible material, such as PET. Furthermore, the polymeric foam can be attached to the outer surface of the 3D woven fabric and can provide a compressible seal with the native annulus.
- In some implementations, docking devices in accordance with the present disclosure can be manufactured to the desired shape at least in part by pressing and/or heating the 3D woven fabric over a shape-setting mold at temperatures above the melting point of the low-melt thermoplastic polymer or resin. The melting of low-melt material can function as an adhesive to set the shape of the fabric. After the desired shape of the 3D woven fabric is set, a foam material can be attached or sewed onto the 3-D woven fabric.
- In some implementations, the present disclosure provides a method for fabricating a universal docking device, wherein a main body of the docking device is made of shape memory material (e.g., Ni—Ti alloy, Nitinol) and thermoplastic fibers by utilizing 3D weaving techniques. Such 3D weaving techniques may be implemented on a specialized 3D weaving machine. For example, in some 3D weaving implementations in accordance with embodiments of the present disclosure, three sets of yarns are used to interlace with each other, as compared to two sets of yarn in flat-woven structures. The weave can be orthogonal or multilayer, and multiple layers can be woven together to form a 3D fabric. In the width-wise (i.e., “filling” or “weft”) direction, memory metal (e.g., Ni—Ti) round wire and low-melt Nylon can be used apart from high tenacity polyethylene terephthalate (PET). The melting temperature of the low-melt nylon resin can be designed to be in range of 166-175° C.
- After weaving the fabric, methods of fabricating a docking device in accordance with one or more embodiments of the present disclosure can involve pressing the fabric over a shape-setting mold (e.g., having a specific custom shape) and heated for a period of time (e.g., 30-60 min) at temperatures higher than the melting point of the low-melt Nylon resin, thereby causing the low-melt nylon to melt. The melted Nylon can act as an adhesive, and can at least partially set the shape of the fabric. The method may further involve leaving the shape-set fabric on the mold to cool-off for a period of time (e.g., 1 hour), and then removing the shape-set fabric and covering the same with a tubular woven fabric filled with foam or other at least partially compressible material (e.g., polymer, biocompatible alloy, etc.). The use of foam, polymer or biocompatible alloy outside the device can advantageously help reduce paravalvular leakage as such material can be compressed during delivery to the annulus, and once deployment is complete, the material can at least partially decompress and form an improved seal. The use of tubular textile around the form or other compressible material can help control the porosity of such materials, as foam or polymeric materials can be undesirably porous; the outside textile (e.g., PET) covering can reduce permeability.
- With reference now to
FIG. 1 of the illustrative drawings, there is shown auniversal docking device 100 in accordance with one or more embodiments. Thedocking device 100 includes a three-dimensional (3D) wovenfabric 10 forming aninternal surface 5, anouter surface 35, and having a thickness therebetween provided by the 3D nature of thefabric 10. In one embodiment, the 3D woven fabric can form a substantiallyhollow cylinder 30 having anouter surface 35 andinner surface 5. In some embodiments, the 3D woven fabric can form a ring, or ring-type form or structure. Other shapes are also possible, depending on the bioprosthetic device being docked within, or on, thedocking device 100. In accordance with some implementations, thedocking device 100 can be interposed between an implantable heart valve and a native valve annulus to provide an improved conforming fit and/or to reduce the likelihood and/or degree of a paravalvular leakage. - The 3D woven
fabric 10 can be a hybrid fabric comprising polyethylene terephthalate (PET), memory metal (e.g., Ni—Ti alloy, Nitinol), and low-melt Nylon alloy, and can be made using any suitable or desirable weaving technique or configuration/arrangement. For example, in the width-wise (i.e., “weft,” “filling”) direction, memory metal (e.g., Ni—Ti) round wire and low-melt Nylon can be used apart from high-tenacity PET, or the memory metal wire can be used entirely the weft/filling direction in order to increase the shape memory effect of the fabric. Thewoven fabric structure 10 can be woven in 2D, 3D, and can be configured to fit any anatomical structure, by using the shape memory effect, or super elastic effect, of the memory metal wire or other material of the fabric. The wovenfabric 10 can be configured to fit any desirable human anatomical part(s) through the use of shape memory alloy to change the shape of the mold. Thefabric 10 can also be used in sheet form as a scaffold for tissue engineering with shape memory effect customized to any human anatomical shape. - In use, the
docking device 100 can be compressed and delivered, such as through a catheter, to the implantation site. At the implantation site, thedocking device 100 can be expanded to fit, and be held at, the local anatomy (e.g., the native heart valve annulus) associated with the implantation site. Thedocking device 100 can then act as a landing site for abioprosthesis 200, such as a transcatheter heart valve. -
FIG. 2 illustrates a perspective view of aframe 200 of an exemplary transcatheter heart valve deployed inside the docking device ofFIG. 1 in accordance with one or more embodiments. With reference toFIG. 2 , thedocking device 100 can be interposed between abioprosthesis 200, such as a transcatheter heart valve (THV), and native tissue, such as a native valve annulus (not shown). AlthoughFIG. 2 only shows the frame of an exemplarytranscatheter heart valve 200 within thedocking device 100, it should be understood that, in some implementations, other devices besides a THV can benefit from implantation within thedocking device 200 and/or other docking devices in accordance with embodiments of the present disclosure. - The
docking device 100 can be configured or designed to be implanted at any suitable or desirable implantation site. However, implantation sites of different patients can present relative irregularity of shapes across patients. By using shape memory effect for thefabric 10, thedocking device 100 can be used to fit into irregular shapes. Thedevice 100 can be configured to be compressed and delivered through a catheter to the implant site. At the delivery site, depending on whether using super-elastic shape memory metal or polymer is used, thedevice 100 can expand by itself or through temperature stimulus to fit the size of the implantation site anatomy (e.g., heart valve annulus). Foam or other compressible material (not shown inFIGS. 1 and 2 ) disposed on the outside of the device 110 can also advantageously fill the open space between the implantation site anatomy (e.g., annulus) and thedevice 100 to create an effective sealing. Thedocking device 100 can act as a landing site for the prosthetic heart valve. -
FIGS. 3A and 3B are perspective views of thedocking device 100 ofFIG. 1 , wherein thedocking device 100 has apolymer foam 40 coupled to anouter surface 35 of thedocking device 100 and a tubular wovenfabric 45 covering thepolymer foam 40 in accordance with one or more embodiments. As shown inFIGS. 3A and 3B , thedocking device 100 can further include a filler 40 (also referred to herein as a “filler structure”) coupled to theouter surface 35 of thehollow cylinder 30. Thefiller 40 can comprise a polymeric foam. The polymeric foam can be an open-celled foam or a closed-cell foam. In some embodiments, thefiller 40 form or structure can be provided to partially or completely surround a circumference of theouter surface 35 of thehollow cylinder 30. In some embodiments, thefiller 40 can include a compressible or expandable material that can fill a desired space. In some embodiments, thefiller 40 can be or comprise a polymer foam. In some embodiments, thefiller 40 can comprise medical-grade silicone and/or a biocompatible alloy. In some embodiments, the filler can comprise one or more of polymeric foam, polyurethane foam, polyvinyl chloride foam, Styrofoam, polyimide foam, silicone foam, and/or microcellular foam. - In use, the
filler structure 40 can be configured to be compressed during delivery of thedocking device 100 to the implantation site (e.g., valve annulus). Once deployed, thefiller 40 can be configured to decompress to provide a compressible seal against the surrounding native tissue. This compressible seal can be optimized by varying the shape, size, and stiffness of thefiller 40. For example, thefiller 40 can be configured, as shown inFIG. 3A , to cover a portion of theouter surface 35 of thehollow cylinder 30. Alternatively, the filler can be configured, as shown inFIG. 3B , to cover substantially all, or at least a majority, of theouter surface 35. In this way, the configuration of the filler can be optimized to enable thedocking device 100 to accommodate itself to complex anatomic geometries and/or, in the case of a prosthetic heart valve, to reduce paravalvular leakage. - In some embodiments, the
filler 40 can be dimensioned to cover at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or 100% of theouter surface 35 of thehollow cylinder 30. In some embodiments, the filler can also be dimensioned to cover a percentage of the outer surface that includes and is between any two of the foregoing values. -
FIG. 4 is a cutaway perspective view of a tubular wovenfabric 45 covering apolymeric foam 40 in accordance with one or more embodiments. In some embodiments, the filler component/structure of a docking device in accordance with aspects of the present disclosure comprises a material that is, by itself, too porous to fully prevent or mitigate paravalvular leakage. Accordingly, with reference toFIG. 4 , in some embodiments, thefiller 40 can be covered with a tubular wovenfabric 45, such as PET. In some embodiments, thefiller 40 can be secured to a docking device, such as thedocking device 100 shown inFIGS. 3A and 3B , by attaching the tubular wovenfabric 45 to theouter surface 35 of the docking device'shollow cylinder 30. For example, the tubular wovenfabric 45 may be attached to theouter surface 35 by adhering or suturing the tubular wovenfabric 45 directly to theouter surface 35. So configured, the tubular woven fabric with its low porosity and reduced permeability, can further mitigate paravalvular leakage. The tubular wovenfabric 45 can also be provided to protect or ensure against the release of any undesired particulate matter from thefiller 40, particularly with respect to embodiments in which thefiller 40 is made of a porous and/or a foam material. Such particulate matter can be released due to the frictional forces imposed on thefiller 40 during the delivery and/or implantation process(es). Release of such particulate matter can be undesirable as presenting a higher risk of embolization. - In some implementations, the present disclosure is related to relatively complex textile structures generated by utilizing weaving, braiding, knitting and/or a combination thereof. Such textiles structures can be generated using shape memory fibers or alloys (e.g., Nitinol) in combination with one or more thermoplastic textile fibers, such as Nylon, polyethylene terephthalate (PET), polypropylene (PP), and/or polybutylene terephthalate (PBT). Hybrid textile structures in accordance with the present disclosure can be created using a base substrate fabric, and using electro-spinning to lay shape memory fibers on top of the substrate fabric, or by wrapping a low-melt Nylon in a core-sheath structure. As described above, the textile structure can be formed into a hollow cylinder form, wherein the outside of the cylinder form is at least partially enveloped by foam, polymer (e.g. medical-grade silicone), and/or a biocompatible alloy.
- Devices in accordance with some implementations can include a three-dimensional (3D) woven fabric that is formed into a hollow cylinder, as well as a polymer foam attached to the hollow cylinder. The 3D woven fabric can advantageously comprise three different types of yarns or fibers, as described in detail herein. For example, the 3D woven fabric can comprise one or more of the following types of yarns and/or fibers: shape memory material, low-melt thermoplastic polymer or resin, and high-tenacity biocompatible material.
- Example embodiments of 3D woven fabrics for use with docking devices are described below. As described above, 3D woven fabrics in accordance with embodiments of the present disclosure can comprise three different types of fibers or yarns. In some embodiments, the three different types of fibers or yarns can comprise a combination of a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. In some embodiments, the shape memory material can be or comprise a metal alloy. The metal alloy can comprise nickel and/or titanium, such as Nitinol. In one embodiment, the shape memory material can provide the desired shape and geometry of the device.
- With respect to the low-melt thermoplastic polymer or resin material, in some embodiments, such material can act as a binder or glue to fuse woven layers of the
3D fabric 10 together and conform the 3D wovenfabric 10 to a desired shape. In some embodiments, the low-melt thermoplastic polymer or resin can be or comprise Nylon, for example. - The low-melt thermoplastic polymer or resin can have a relatively low-melting point. In accordance with an optional aspect, the low-melting point of the low-melt thermoplastic polymer or resin can be 200o C or less, 195° C. or less, 190° C. or less, 185° C. or less, 180° C. or less, 175° C. or less, 170° C. or less, 165° C. or less, 160° C. or less, 155° C. or less, 150° C. or less, 145° C. or less, 140° C. or less, 135° C. or less, 130° C. or less, 125° C. or less, 120° C. or less, 115° C. or less, 110° C. or less, 105° C. or less, and 100° C. or less. The low-melting point can be within a range that includes and is between any two of the foregoing values.
- With respect to the high-tenacity biocompatible material, such material can improve the durability of the 3D woven
fabric 10 and promote tissue growth. In some embodiments, the high-tenacity biocompatible material can have a tenacity, or breaking load, of about 5 grams per Denier or more, about 6 grams per Denier or more, about 7 grams per Denier or more, about 8 grams per Denier or more, about 9 grams per Denier or more, about 10 grams per Denier or more, about 11 grams per Denier or more, about 12 grams per Denier or more, about 13 grams per Denier or more, about 14 grams per Denier or more, or about 15 grams per Denier. The breaking load can also be within a range that includes and/or is between any two of the foregoing values. In some embodiments, the high-tenacity biocompatible material can be PET. - In another embodiment, methods for making a
docking device 100 for abioprosthesis 200 are described. One such method comprises weaving a 3D wovenfabric 10 by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material. The shape memory material can be a metal alloy. The metal alloy can comprise nickel and titanium, such as Nitinol. The low-melt thermoplastic polymer or resin can be a polymer having a low-melting point. The polymer can be nylon. The high-tenacity biocompatible material can be PET. - 3D woven fabrics can generally be woven by manipulating yarns in the length (“warp,” or “ends”), width (“weft,” “filling,” or “picks”), and through-the-thickness directions. In some embodiments, the combination of the low-melt thermoplastic polymer and the 3D weave pattern can allow the thickness of the 3D woven fabric to be varied based on the number of layers of the weft and warp yarns. Thus, in one aspect, the thickness of the 3D woven fabric can be increased by increasing the number of layers of the weft and warp yarns with the low-melt thermoplastic polymer and the through-the-thickness yarns binding the plurality of layers together.
- The through-the-thickness yarn can be incorporated at varying levels and angles within orthogonal (
FIG. 5A ), multilayer (FIG. 5B ), and angle-interlock (FIG. 5C ) woven structures to obtain desired mechanical properties. The weaving step can be performed on conventional weaving machines or specially-made weaving machines. In some embodiments, braiding or knitting techniques can be employed to manufacture the 3D fabric. However, in some implementations, such methods may not produce sufficient thickness. - With reference to
FIG. 5A , in one embodiment, the 3D wovenfabric 10 can comprise an orthogonal weave structure. Orthogonal weave structures can include a set ofwarp yarns 15, a set of fillingyarns 20, and a set of through-the-thickness yarns 25.Warp yarns 15 can be placed in the fabric length direction and fillingyarns 20 can be inserted between the length layers to form double picks. Through-the-thickness yarns 25 can interconnect the other two yarn sets and provide structural integrity. The thickness of the orthogonal structure can be formed by the number of layers of the warp or weft yarn. In some embodiments, yarns are substantially straight in the warp, weft, and through-the-thickness directions. The through-the-thickness yarns can generally travel vertically between the top and bottom weft yarn layers, and can also interlink with weft yarn layers at other levels in some embodiments. - In some embodiments, the 3D woven
fabric 10 can comprise an orthogonal weave structure, wherein the set ofwarp yarns 15 can comprise a shape memory material, the set of fillingyarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of through-the-thickness yarns 25 can comprise a high-tenacity biocompatible material. - In some embodiments, the 3D woven
fabric 10 can comprise an orthogonal weave structure, wherein the set ofwarp yarns 15 can comprise a high-tenacity biocompatible material, the set of fillingyarns 20 can comprise a shape memory material, and the set of through-the-thickness yarns 25 can comprise a low-melt thermoplastic polymer or resin. - With reference to
FIG. 5B , in some embodiments, the 3D wovenfabric 10 can comprise a multilayer weave structure. Multilayer weave structures can include a set ofwarp yarns 15, a set ofweft yarns 20, and a set of through-the-thickness binding yarns 25.Warp yarns 15 can be interlaced withweft yarns 20 at each layer according to the weave pattern in in-plane principal directions, whereas bindingyarns 25 can be interlaced withwarp yarns 15 at each layer according to the weave pattern in out-of-plane principal directions. The multilayer weave structure can be fully interlaced or semi-interlaced. - In some embodiments, the 3D woven
fabric 10 can comprise a multilayer weave structure, wherein the set ofwarp yarns 15 can comprise a shape memory material, the set ofweft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set of bindingyarns 25 can comprise a high-tenacity biocompatible material. - In some embodiments, the 3D woven
fabric 10 can comprise a multilayer weave structure, wherein the set ofwarp yarns 15 can comprise a high-tenacity biocompatible material, the set ofweft yarns 20 can comprise a shape memory material, and the set of bindingyarns 25 can comprise a low-melt thermoplastic polymer or resin. - With reference to
FIG. 5C , in some embodiments, the 3D wovenfabric 10 comprises an angle-interlock weave structure. Angle-interlock weave structures in accordance with the present disclosure can include a set ofwarp yarns 15, a set of straight weft yarns 20 (wadding), and a set ofbias weft yarns 25 that weave with thewarp yarns 15 in a diagonal direction in the thickness. In layer-to-layer angle-interlock weaves (not shown),bias weft yarns 25 can travel between two or more successive layers making interlacements withseveral wadding yarns 20 according to the weave pattern. In through-thickness angle-interlock weaves (FIG. 5C ),bias weft yarns 25 can bind diagonally from the top layer to the bottom layer. - In some embodiments, the 3D woven
fabric 10 can comprise an angle-interlock structure, wherein the set ofwarp yarns 15 can comprise a shape memory material, the set ofstraight weft yarns 20 can comprise a low-melt thermoplastic polymer or resin, and the set ofbias weft yarns 25 can comprise a high-tenacity biocompatible material. - In some embodiments, the 3D woven
fabric 10 can comprise an angle-interlock structure, wherein the set ofwarp yarns 15 can comprise a high-tenacity biocompatible material, the set ofstraight weft yarns 20 can comprise a shape memory material, and the set ofbias weft yarns 25 can comprise a low-melt thermoplastic polymer or resin. - It should be understood that other varieties of 3D weave structures, including different varieties of orthogonal, multilayer, and angle-interlock weave structures, may be used in connection with embodiments of the present disclosure. To optimize the physical characteristics of the
docking device 100 for use with aparticular bioprosthesis 200 or installation site, the 3D wovenfabric 10 can be manufactured using any of the different varieties of 3D weave structures. - For example, in use with a bioprosthetic heart valve, the
docking device 100 may be subjected to compressive forces between thebioprosthesis 200 and the surrounding native valve tissue. The compressibility of thedocking device 100 can be, in part, a function of the compressibility of the 3D woven fabric, which can, in turn, be a function of the fabric's weave structure, fabric density, and/or other characteristics of the constituent fibers/yarns. Accordingly, the 3D woven fabric's 10 weave structure and fabric density can be selected to optimize the compressibility ofdocking device 100. - Fabric density can be quantified by ends-per-inch (EPI) and/or picks-per-inch (PPI). In some embodiments, the 3D woven
fabric 10 can have about 115 EPI, about 120 EPI, about 125 EPI, about 130 EPI, about 135 EPI, about 140 EPI, about 145 EPI, about 150 EPI, about 155 EPI, about 160 EPI, about 165 EPI, about 170 EPI, about 175 EPI, about 180 EPI, about 185 EPI, about 190 EPI, about 195 EPI, about 200 EPI, about 205 EPI, about 210 EPI, about 215 EPI, about 220 EPI, about 225 EPI, about 230 EPI, about 235 EPI, about 240 EPI, about 245 EPI, about 250 EPI, about 255 EPI, about 260 EPI, about 265 EPI, about 270 EPI, about 275 EPI, about 280 EPI, about 285 EPI, about 290 EPI, about 295 EPI, about 300 EPI, about 305 EPI, about 310 EPI, about 315 EPI, about 320 EPI, about 325 EPI, about 330 EPI, about 335 EPI, about 340 EPI, about 345 EPI, or about 350 EPI. In some embodiments, the 3D wovenfabric 10 can have ends-per-inch between and including any two of the foregoing values. - In one embodiment, the 3D woven
fabric 10 can have about 115 PPI, about 120 PPI, about 125 PPI, about 130 PPI, about 135 PPI, about 140 PPI, about 145 PPI, about 150 PPI, about 155 PPI, about 160 PPI, about 165 PPI, about 170 PPI, about 175 PPI, about 180 PPI, about 185 PPI, about 190 PPI, about 195 PPI, about 200 PPI, about 205 PPI, about 210 PPI, about 215 PPI, about 220 PPI, about 225 PPI, about 230 PPI, about 235 PPI, about 240 PPI, about 245 PPI, about 250 PPI, about 255 PPI, about 260 PPI, about 265 PPI, about 270 PPI, about 275 PPI, about 280 PPI, about 285 PPI, about 290 PPI, about 295 PPI, about 300 PPI, about 305 PPI, about 310 PPI, or about 315 PPI, about 320 PPI, about 325 PPI, about 330 PPI, about 335 PPI, about 340 PPI, about 345 PPI, or about 350 PPI. In some embodiments, the 3D wovenfabric 10 can have picks-per-inch between and including any two of the foregoing values. - In some embodiments, the
docking device 100 exhibits a compressibility of no more than 5%, no more than 10%, no more than 15%, no more than 20%, no more than 25%, no more than 30%, no more than 35%, no more than 40%, no more than 45%, no more than 50%, no more than 55%, no more than 60%, no more than 65%, or no more than 70% across its thickness. In some embodiments, the docking device can exhibit a compressibility of between and including any two of the foregoing values. - With reference to
FIG. 6 , a method for making adocking device 100 for a bioprosthesis can comprise the step of pressing and heating the 3D wovenfabric 10 over a shape-settingmold 50 at temperatures greater than the melting point of the low-melt thermoplastic polymer or resin. This step can melt the low-melt thermoplastic polymer or resin yarn, which can function as an adhesive to set the shape of the 3D wovenfabric 10 as desired. In some embodiments, the 3D wovenfabric 10 can be heated on the shape-settingmold 50 from about 30 minutes to about 60 minutes. In some embodiments, the bioprosthesis can be a transcatheter heart valve, and the 3D wovenfabric 10 can be molded accordingly. It should be understood, however, that the 3D wovenfabric 10 can be molded to accommodate other bioprostheses, or as a scaffold for tissue engineering. - In some embodiments, the method can further comprise the step of attaching a
filler 40 to asurface 35 of the 3D wovenfabric 10, for example by sewing thefiller 40 to thesurface 35 of the 3D wovenfabric 10. In a further embodiment, the method can include the step of covering thefiller 40 with a tubular wovenfabric 45 comprising, for example, polyethylene terephthalate (PET). In some embodiments, thefiller 40 can be a polymer foam. - It should be appreciated from the foregoing description that the present invention provides a universal docking device that can be radially compressible, for delivery and implantation, and that changes shape and recovers after a deforming stress is removed. The docking device adjusts to surrounding conditions to accommodate different complex anatomic geometries, and provides conforming support while minimizing or eliminating leakage around the implanted device.
- The invention has been described in detail with reference only to the presently preferred embodiments. Persons skilled in the art will appreciate that various modifications can be made without departing from the invention. Accordingly, the invention is defined only by the following claims.
- Depending on the embodiment, certain acts, events, or functions of any of the processes described herein can be performed in a different sequence, may be added, merged, or left out altogether. Thus, in some embodiments, not all described acts or events are necessary for the practice of the processes. Moreover, in some embodiments, acts or events may be performed concurrently.
- Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that some embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous, are used in their ordinary sense, and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Conjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, element, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that some embodiments require at least one of X, at least one of Y and at least one of Z to each be present.
- It should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Moreover, any components, features, or steps illustrated and/or described in a particular embodiment herein can be applied to or used with any other embodiment(s). Further, no component, feature, step, or group of components, features, or steps are necessary or indispensable for each embodiment. Thus, it is intended that the scope of the inventions herein disclosed and claimed below should not be limited by the particular embodiments described above, but should be determined only by a fair reading of the claims that follow.
Claims (20)
1. A method of fabricating a docking device, the method comprising:
implementing a three-dimensional (3D) weaving technique to form a 3D textile structure using a plurality of different types of fibers;
heating the 3D textile structure on a shape-setting mold at a temperature above a melting point of a first type of fiber of the plurality of different types of fibers to set a cylindrical shape of the 3D textile structure;
maintaining the 3D textile structure on the shape-setting mold to cool off for a period of time; and
removing the 3D textile structure from the shape-setting mold.
2. The method of claim 1 , further comprising:
covering a compressible filler structure with fabric; and
attaching the fabric to an outer surface of the 3D textile structure.
3. The method of claim 2 , wherein the fabric comprises 3D woven fabric.
4. The method of claim 3 , wherein the 3D woven fabric has a similar structure and composition as the 3D textile structure.
5. The method of claim 1 , wherein said implementing the 3D weaving technique involves interlacing shape memory fibers, low-melt thermoplastic fibers, and high-tenacity biocompatible material fibers.
6. The method of claim 1 , wherein the 3D weaving technique is one of:
an orthogonal weaving technique;
a multilayer weaving technique; or
an angle-interlock weaving technique.
7. The method of claim 1 , further comprising wrapping the 3D textile structure around the shape-setting mold to form the 3D textile structure in a hollow cylindrical form.
8. The method of claim 1 , wherein the temperature is below melting points of second and third types of fiber of the plurality of different types of fibers.
9. A method of fabricating a docking device, the method comprising:
weaving a three-dimensional (3D) woven fabric by interlacing a shape memory material, a low-melt thermoplastic polymer or resin, and a high-tenacity biocompatible material; and
pressing and heating the 3D woven fabric over a shape-setting mold at temperatures greater than a melting point of the low-melt thermoplastic polymer or resin.
10. The method of claim 9 , wherein:
the shape memory material comprises nitinol;
the low-melt thermoplastic polymer or resin comprises nylon having a melting point of between 85 degrees Celsius and 200 degrees Celsius; and
the high-tenacity biocompatible material comprises polyethylene terephthalate (PET).
11. The method of claim 9 , further comprising attaching a filler structure to a surface of the 3D woven fabric.
12. The method of claim 11 , wherein said attaching the filler structure comprises sewing the filler structure to an outer surface of the 3D woven fabric.
13. The method of claim 12 , further comprising covering the filler structure with a tubular woven fabric comprising PET, wherein the filler structure comprises polymer foam.
14. A method of using a docking device, the method comprising:
providing a shape-set hollow cylindrical docking device formed at least in part of a three-dimensional (3D) woven fabric comprising a plurality of different types of fibers, the docking device having an elongate foam structure wrapped at least partially around an outer circumference of the docking device;
compressing the 3D woven fabric and the elongate foam structure to configure the docking device in a compressed configuration;
placing the docking device in a delivery catheter in the compressed configuration;
advancing the delivery catheter to a target implantation site;
deploying the docking device at the target implantation site;
allowing the 3D woven fabric and the elongate foam structure to expand to form to a seal against a native annulus at the target implantation site; and
placing a prosthetic implant device at least partially within the docking device.
15. The method of claim 14 , further comprising using a temperature stimulus to expand the 3D woven fabric after said deploying the docking device.
16. The method of claim 14 , wherein the 3D woven fabric comprises:
warp fibers of a first type of fiber of the plurality of different types of fibers;
weft fibers of a second type of fiber of the plurality of different types of fibers; and
through-the-thickness fibers of a third type of fiber of the plurality of different types of fibers.
17. The method of claim 14 , wherein the plurality of different types of fibers comprises:
a shape memory type of fiber;
a low-melt thermoplastic type of fiber; and
a high-tenacity biocompatible type of fiber.
18. The method of claim 14 , wherein the docking device is deployed within a native heart valve.
19. The method of claim 18 , further comprising inhibiting paravalvular leakage using the foam structure.
20. The method of claim 14 , wherein the prosthetic implant device is a transcatheter heart valve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/448,035 US20230390049A1 (en) | 2016-12-20 | 2023-08-10 | Implant fabrication using three-dimensional woven fabric |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662436866P | 2016-12-20 | 2016-12-20 | |
US15/841,046 US10813749B2 (en) | 2016-12-20 | 2017-12-13 | Docking device made with 3D woven fabric |
US17/071,641 US11759317B2 (en) | 2016-12-20 | 2020-10-15 | Three-dimensional woven fabric implant devices |
US18/448,035 US20230390049A1 (en) | 2016-12-20 | 2023-08-10 | Implant fabrication using three-dimensional woven fabric |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/071,641 Division US11759317B2 (en) | 2016-12-20 | 2020-10-15 | Three-dimensional woven fabric implant devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230390049A1 true US20230390049A1 (en) | 2023-12-07 |
Family
ID=62556538
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/841,046 Active US10813749B2 (en) | 2016-12-20 | 2017-12-13 | Docking device made with 3D woven fabric |
US17/071,641 Active 2038-10-03 US11759317B2 (en) | 2016-12-20 | 2020-10-15 | Three-dimensional woven fabric implant devices |
US18/448,035 Pending US20230390049A1 (en) | 2016-12-20 | 2023-08-10 | Implant fabrication using three-dimensional woven fabric |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/841,046 Active US10813749B2 (en) | 2016-12-20 | 2017-12-13 | Docking device made with 3D woven fabric |
US17/071,641 Active 2038-10-03 US11759317B2 (en) | 2016-12-20 | 2020-10-15 | Three-dimensional woven fabric implant devices |
Country Status (5)
Country | Link |
---|---|
US (3) | US10813749B2 (en) |
EP (1) | EP3558167B1 (en) |
CN (2) | CN110234299B (en) |
CA (1) | CA3047139A1 (en) |
WO (1) | WO2018118796A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11008676B2 (en) * | 2015-12-16 | 2021-05-18 | Edwards Lifesciences Corporation | Textured woven fabric for use in implantable bioprostheses |
US11833034B2 (en) | 2016-01-13 | 2023-12-05 | Shifamed Holdings, Llc | Prosthetic cardiac valve devices, systems, and methods |
US11160653B2 (en) | 2017-03-27 | 2021-11-02 | Truleaf Medicai Ltd. | Docking elements |
US11395738B2 (en) * | 2018-09-25 | 2022-07-26 | Truleaf Medical Ltd. | Docking elements |
JP2022504241A (en) | 2018-10-05 | 2022-01-13 | シファメド・ホールディングス・エルエルシー | Artificial heart valve device, system, and method |
EP3941391A4 (en) | 2019-03-19 | 2022-11-23 | Shifamed Holdings, LLC | Prosthetic cardiac valve devices, systems, and methods |
CN113133853A (en) * | 2020-01-20 | 2021-07-20 | 楚利福医疗有限公司 | Apparatus and method for use with a mitral valve |
Family Cites Families (166)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1392535A (en) * | 1919-06-18 | 1921-10-04 | William D Stevenson | Composite article including phenols and formaldehyde and method of making same |
US3365728A (en) | 1964-12-18 | 1968-01-30 | Edwards Lab Inc | Upholstered heart valve having a sealing ring adapted for dispensing medicaments |
US3725961A (en) | 1970-12-29 | 1973-04-10 | Baxter Laboratories Inc | Prosthetic heart valve having fabric suturing element |
US3971670A (en) * | 1974-07-17 | 1976-07-27 | Homsy Charles A | Implantable structure and method of making same |
US3983581A (en) | 1975-01-20 | 1976-10-05 | William W. Angell | Heart valve stent |
US4035849A (en) | 1975-11-17 | 1977-07-19 | William W. Angell | Heart valve stent and process for preparing a stented heart valve prosthesis |
US4182618A (en) * | 1978-04-18 | 1980-01-08 | The Hoover Company | Fastening arrangement for upper fill tube on a soft bag cleaner |
US4187618A (en) * | 1978-04-21 | 1980-02-12 | The Orr Felt Company | Papermakers' felt |
JPS60199955A (en) * | 1984-03-23 | 1985-10-09 | 工業技術院長 | Method and apparatus for weaving three-dimensional fiber structure |
US4854352A (en) * | 1987-02-06 | 1989-08-08 | J. B. Martin Company | Textile fabrics having a plurality of warp and filling layers and attendant method of making |
IT1240110B (en) * | 1990-02-21 | 1993-11-27 | Sorin Biomedica Spa | CARDIAC VALVE PROSTHESIS |
US5059177A (en) | 1990-04-19 | 1991-10-22 | Cordis Corporation | Triple lumen balloon catheter |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5399418A (en) * | 1991-12-21 | 1995-03-21 | Erno Raumfahrttechnik Gmbh | Multi-ply textile fabric especially for protection suits and the like |
US5258023A (en) | 1992-02-12 | 1993-11-02 | Reger Medical Development, Inc. | Prosthetic heart valve |
CA2149900C (en) | 1993-09-24 | 2003-06-24 | Yasuo Shikinami | Implant material |
WO1995013033A1 (en) | 1993-11-08 | 1995-05-18 | Lazarus Harrison M | Intraluminal vascular graft and method |
US5476506A (en) | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US5478638A (en) * | 1994-07-15 | 1995-12-26 | Springer; Gary B. | Reinforced conveyor belt comprising a multi-layer structure with at least one intermediate fabric layer containing spaced reinforcing steel rods in the weft of the fabric layer |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
US5628786A (en) | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
WO1996040011A1 (en) | 1995-06-07 | 1996-12-19 | St. Jude Medical, Inc. | Direct suture orifice for mechanical heart valve |
US5571175A (en) | 1995-06-07 | 1996-11-05 | St. Jude Medical, Inc. | Suture guard for prosthetic heart valve |
DE19532846A1 (en) | 1995-09-06 | 1997-03-13 | Georg Dr Berg | Valve for use in heart |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US6193745B1 (en) | 1995-10-03 | 2001-02-27 | Medtronic, Inc. | Modular intraluminal prosteheses construction and methods |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
DE69732411T2 (en) | 1996-06-20 | 2006-01-19 | Vascutek Ltd., Renfrewshire | Repair of body vessels by prostheses |
US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5843161A (en) | 1996-06-26 | 1998-12-01 | Cordis Corporation | Endoprosthesis assembly for percutaneous deployment and method of deploying same |
GB9614950D0 (en) | 1996-07-16 | 1996-09-04 | Anson Medical Ltd | A ductus stent and delivery catheter |
US5755783A (en) | 1996-07-29 | 1998-05-26 | Stobie; Robert | Suture rings for rotatable artificial heart valves |
CN1066220C (en) * | 1996-10-28 | 2001-05-23 | 王光华 | Three dimension stereo fabric for composite material and weaving method |
US6206911B1 (en) | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US6015431A (en) | 1996-12-23 | 2000-01-18 | Prograft Medical, Inc. | Endolumenal stent-graft with leak-resistant seal |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6306164B1 (en) | 1997-09-05 | 2001-10-23 | C. R. Bard, Inc. | Short body endoprosthesis |
US6352554B2 (en) | 1998-05-08 | 2002-03-05 | Sulzer Vascutek Limited | Prosthetic tubular aortic conduit and method for manufacturing the same |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6527979B2 (en) | 1999-08-27 | 2003-03-04 | Corazon Technologies, Inc. | Catheter systems and methods for their use in the treatment of calcified vascular occlusions |
US20040267349A1 (en) | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
IL144593A0 (en) | 1999-01-27 | 2002-05-23 | Viacor Inc | Cardiac valve procedure methods and devices |
DE19907646A1 (en) | 1999-02-23 | 2000-08-24 | Georg Berg | Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire. |
US7147663B1 (en) | 1999-04-23 | 2006-12-12 | St. Jude Medical Atg, Inc. | Artificial heart valve attachment apparatus and methods |
US6312465B1 (en) | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
FR2815844B1 (en) | 2000-10-31 | 2003-01-17 | Jacques Seguin | TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6663667B2 (en) | 1999-12-29 | 2003-12-16 | Edwards Lifesciences Corporation | Towel graft means for enhancing tissue ingrowth in vascular grafts |
DK1255510T5 (en) | 2000-01-31 | 2009-12-21 | Cook Biotech Inc | Stent Valve Klapper |
WO2001056512A1 (en) | 2000-02-02 | 2001-08-09 | Snyders Robert V | Artificial heart valve |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US20050070999A1 (en) | 2000-02-02 | 2005-03-31 | Spence Paul A. | Heart valve repair apparatus and methods |
KR20020082861A (en) | 2000-03-03 | 2002-10-31 | 쿡 인코포레이티드 | Endovascular device having a stent |
US20030070683A1 (en) | 2000-03-04 | 2003-04-17 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US6729356B1 (en) | 2000-04-27 | 2004-05-04 | Endovascular Technologies, Inc. | Endovascular graft for providing a seal with vasculature |
US20050043757A1 (en) | 2000-06-12 | 2005-02-24 | Michael Arad | Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US7077861B2 (en) | 2000-07-06 | 2006-07-18 | Medtentia Ab | Annuloplasty instrument |
US6846325B2 (en) | 2000-09-07 | 2005-01-25 | Viacor, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US6814754B2 (en) | 2000-10-30 | 2004-11-09 | Secant Medical, Llc | Woven tubular graft with regions of varying flexibility |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
WO2002047575A2 (en) | 2000-12-15 | 2002-06-20 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with valve |
US6773456B1 (en) | 2001-03-23 | 2004-08-10 | Endovascular Technologies, Inc. | Adjustable customized endovascular graft |
US7037334B1 (en) | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US7510571B2 (en) | 2001-06-11 | 2009-03-31 | Boston Scientific, Scimed, Inc. | Pleated composite ePTFE/textile hybrid covering |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
EP1432369B1 (en) | 2001-08-31 | 2008-02-27 | Mitral Interventions | Apparatus for valve repair |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7192441B2 (en) | 2001-10-16 | 2007-03-20 | Scimed Life Systems, Inc. | Aortic artery aneurysm endovascular prosthesis |
AUPR847201A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
US6911040B2 (en) | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
US20030225420A1 (en) | 2002-03-11 | 2003-12-04 | Wardle John L. | Surgical coils and methods of deploying |
WO2003088873A1 (en) | 2002-04-16 | 2003-10-30 | Viacor, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
DE10221076A1 (en) | 2002-05-11 | 2003-11-27 | Ruesch Willy Gmbh | stent |
AU2002367970A1 (en) | 2002-05-17 | 2003-12-02 | Bionethos Holding Gmbh | Medical device for the treatment of a body vessel or another tubular structure in the body |
US7264632B2 (en) | 2002-06-07 | 2007-09-04 | Medtronic Vascular, Inc. | Controlled deployment delivery system |
US7101395B2 (en) | 2002-06-12 | 2006-09-05 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US7044962B2 (en) | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
US7175652B2 (en) | 2002-08-20 | 2007-02-13 | Cook Incorporated | Stent graft with improved proximal end |
US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
US20040098096A1 (en) | 2002-10-22 | 2004-05-20 | The University Of Miami | Endograft device to inhibit endoleak and migration |
JP4940388B2 (en) | 2003-04-24 | 2012-05-30 | クック メディカル テクノロジーズ エルエルシー | Prosthetic valve prosthesis with improved hydrodynamic properties |
US20040215320A1 (en) | 2003-04-25 | 2004-10-28 | James Machek | Integral stent graft |
US7101396B2 (en) | 2003-10-06 | 2006-09-05 | 3F Therapeutics, Inc. | Minimally invasive valve replacement system |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US20050137691A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
EP2745805B2 (en) | 2003-12-23 | 2022-05-18 | Boston Scientific Scimed, Inc. | Repositionable heart valve |
DK2749254T4 (en) | 2003-12-23 | 2020-02-03 | Boston Scient Scimed Inc | Repositionable heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US20070293927A1 (en) | 2004-02-17 | 2007-12-20 | The Children's Hospital Of Philadelphia | Gene and Cell Delivery Self Expanding Polymer Stents |
US20090132035A1 (en) | 2004-02-27 | 2009-05-21 | Roth Alex T | Prosthetic Heart Valves, Support Structures and Systems and Methods for Implanting the Same |
US20070073387A1 (en) | 2004-02-27 | 2007-03-29 | Forster David C | Prosthetic Heart Valves, Support Structures And Systems And Methods For Implanting The Same |
CA2813136A1 (en) | 2004-02-27 | 2005-09-15 | Aortx, Inc. | Prosthetic heart valve delivery systems and methods |
WO2005087140A1 (en) | 2004-03-11 | 2005-09-22 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
AU2005234793B2 (en) | 2004-04-23 | 2012-01-19 | 3F Therapeutics, Inc. | Implantable prosthetic valve |
US7276078B2 (en) | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
US20060089672A1 (en) | 2004-10-25 | 2006-04-27 | Jonathan Martinek | Yarns containing filaments made from shape memory alloys |
EP1853199B1 (en) | 2005-02-28 | 2014-10-29 | Medtentia International Ltd Oy | Devices for improving the function of a heart valve |
CA2843097C (en) | 2005-05-24 | 2015-10-27 | Inspire M.D Ltd. | Stent apparatuses for treatment via body lumens and methods of use |
CA2619022C (en) | 2005-09-07 | 2015-04-07 | Medtentia Ab | A device and method for improving the function of a heart valve |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
JP4982502B2 (en) | 2005-12-07 | 2012-07-25 | メドトロニック,インコーポレイテッド | Coupling system for a two-piece heart valve assembly |
US8147541B2 (en) | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
US7737060B2 (en) | 2006-03-31 | 2010-06-15 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
SE530568C2 (en) | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
US20080208327A1 (en) | 2007-02-27 | 2008-08-28 | Rowe Stanton J | Method and apparatus for replacing a prosthetic valve |
US8177834B2 (en) | 2007-03-12 | 2012-05-15 | Cook Medical Technologies Llc | Woven fabric with shape memory element strands |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
JP5367700B2 (en) | 2007-06-04 | 2013-12-11 | セント ジュード メディカル インコーポレイテッド | Prosthetic heart valve |
US8425593B2 (en) | 2007-09-26 | 2013-04-23 | St. Jude Medical, Inc. | Collapsible prosthetic heart valves |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
EP2299938B1 (en) | 2008-07-15 | 2021-03-03 | St. Jude Medical, LLC | Collapsible and re-expandable prosthetic heart valve cuff designs and complementary technological applications |
KR101707249B1 (en) | 2008-12-15 | 2017-02-15 | 알러간, 인코포레이티드 | A prosthetic device and method of manufacturing the same |
US8414644B2 (en) | 2009-04-15 | 2013-04-09 | Cardiaq Valve Technologies, Inc. | Vascular implant and delivery system |
WO2010127041A1 (en) | 2009-04-29 | 2010-11-04 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
DK2434984T3 (en) | 2009-05-30 | 2016-05-30 | Inst Für Textil Und Faserforschung Denkendorf Stiftung Des Öffentlichen Rechts Deutsche | medical Product |
US8348998B2 (en) * | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
US8377115B2 (en) | 2009-11-16 | 2013-02-19 | Medtronic Vascular, Inc. | Implantable valve prosthesis for treating venous valve insufficiency |
ES2922283T3 (en) | 2010-03-05 | 2022-09-12 | Edwards Lifesciences Corp | Retention mechanisms for prosthetic valves |
US8657872B2 (en) | 2010-07-19 | 2014-02-25 | Jacques Seguin | Cardiac valve repair system and methods of use |
CA2809909A1 (en) | 2010-09-01 | 2012-03-08 | Julie A. Logan | Cardiac valve support structure |
CN103228300A (en) | 2010-09-07 | 2013-07-31 | 保罗·A·斯彭斯 | Cannula systems and methods |
EP2723272A4 (en) * | 2011-06-24 | 2015-01-28 | Inceptus Medical LLC | Percutaneously implantable artificial heart valve system and associated methods and devices |
US9364326B2 (en) | 2011-06-29 | 2016-06-14 | Mitralix Ltd. | Heart valve repair devices and methods |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
AU2012307020B2 (en) | 2011-09-09 | 2015-04-30 | Endoluminal Sciences Pty Ltd | Means for controlled sealing of endovascular devices |
US20130190857A1 (en) * | 2011-09-09 | 2013-07-25 | Endoluminal Sciences Pty Ltd. | Means for controlled sealing of endovascular devices |
US20130331929A1 (en) * | 2011-09-09 | 2013-12-12 | Endoluminal Sciences Pty Ltd. | Means for Controlled Sealing of Endovascular Devices |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
EP2620125B1 (en) | 2012-01-24 | 2017-10-11 | Medtentia International Ltd Oy | An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve |
JP6049761B2 (en) | 2012-01-31 | 2016-12-21 | マイトラル・ヴァルヴ・テクノロジーズ・エス・アー・エール・エル | Mitral valve docking device, system, and method |
JP5607695B2 (en) | 2012-09-13 | 2014-10-15 | ファナック株式会社 | Machine tool thermal displacement compensation device |
EP4162902A1 (en) | 2012-11-21 | 2023-04-12 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic heart valves |
US9675451B2 (en) * | 2013-02-01 | 2017-06-13 | Medtronic CV Luxembourg S.a.r.l. | Anti-paravalvular leakage component for a transcatheter valve prosthesis |
US9119713B2 (en) | 2013-03-11 | 2015-09-01 | St. Jude Medical, Cardiology Division, Inc. | Transcatheter valve replacement |
US9636222B2 (en) | 2013-03-12 | 2017-05-02 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak protection |
US9326856B2 (en) | 2013-03-14 | 2016-05-03 | St. Jude Medical, Cardiology Division, Inc. | Cuff configurations for prosthetic heart valve |
EP2805695A1 (en) | 2013-05-21 | 2014-11-26 | Medtentia International Ltd Oy | Medical system for annuloplasty |
SG10201805117UA (en) | 2013-08-12 | 2018-07-30 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
US10226330B2 (en) | 2013-08-14 | 2019-03-12 | Mitral Valve Technologies Sarl | Replacement heart valve apparatus and methods |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
US10098734B2 (en) * | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US10512541B2 (en) | 2014-02-18 | 2019-12-24 | Medtentia International Ltd. Oy | Medical device for a cardiac valve implant |
MX2016010460A (en) | 2014-02-20 | 2017-02-27 | Mitral Valve Tech Sarl | Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device. |
US9700412B2 (en) | 2014-06-26 | 2017-07-11 | Mitralix Ltd. | Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices |
BR112017004430A2 (en) | 2014-09-08 | 2017-12-05 | Medtentia Int Ltd Oy | annuloplasty implant |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
US10080652B2 (en) * | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
CN104786564A (en) | 2015-05-20 | 2015-07-22 | 海安县兄弟合成纤维有限公司 | Shape memory compound fabric |
EP3322381B1 (en) * | 2015-07-16 | 2020-10-21 | St. Jude Medical, Cardiology Division, Inc. | Sutureless prosthetic heart valve |
US11008676B2 (en) * | 2015-12-16 | 2021-05-18 | Edwards Lifesciences Corporation | Textured woven fabric for use in implantable bioprostheses |
US10179043B2 (en) * | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
US10837132B2 (en) * | 2016-09-06 | 2020-11-17 | Uchino Co., Ltd. | Multiple gauze fabric |
WO2019012983A1 (en) * | 2017-07-13 | 2019-01-17 | 株式会社 豊田自動織機 | Fiber structure and fiber-reinforced composite material |
-
2017
- 2017-12-13 US US15/841,046 patent/US10813749B2/en active Active
- 2017-12-18 CN CN201780085479.5A patent/CN110234299B/en active Active
- 2017-12-18 CA CA3047139A patent/CA3047139A1/en active Pending
- 2017-12-18 CN CN202211539546.5A patent/CN115957380A/en active Pending
- 2017-12-18 WO PCT/US2017/067056 patent/WO2018118796A1/en unknown
- 2017-12-18 EP EP17883142.6A patent/EP3558167B1/en active Active
-
2020
- 2020-10-15 US US17/071,641 patent/US11759317B2/en active Active
-
2023
- 2023-08-10 US US18/448,035 patent/US20230390049A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3558167B1 (en) | 2024-03-13 |
US20180168804A1 (en) | 2018-06-21 |
EP3558167A1 (en) | 2019-10-30 |
US20210022852A1 (en) | 2021-01-28 |
CA3047139A1 (en) | 2018-06-28 |
CN110234299B (en) | 2022-12-20 |
US11759317B2 (en) | 2023-09-19 |
CN110234299A (en) | 2019-09-13 |
WO2018118796A1 (en) | 2018-06-28 |
EP3558167A4 (en) | 2020-02-19 |
CN115957380A (en) | 2023-04-14 |
US10813749B2 (en) | 2020-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230390049A1 (en) | Implant fabrication using three-dimensional woven fabric | |
EP3893807B1 (en) | Fabric material for medical devices | |
CN108368648B (en) | Textured braid for implantable bioprosthesis | |
EP2171143B1 (en) | Compressible resilient fabric, devices, and methods | |
JPH1033692A (en) | Stent covered with three-dimensional woven structure | |
EP4165239A1 (en) | Stabilized fabric material for medical devices | |
US11547557B2 (en) | Stabilized fabric material for medical devices | |
CN215688783U (en) | Implantable prosthetic valve | |
US20240099832A1 (en) | Prosthetic Leaflets for Valve Replacement | |
WO2021251974A1 (en) | Fabric material for medical devices | |
JP7504516B2 (en) | HEART VALVE ASSEMBLY AND METHOD OF MANUFACTURING SAME - Patent application | |
WO2023150262A1 (en) | Prosthetic valve having laminated skirt assembly with reduced overall thickness and increased stretchability | |
WO2013111877A1 (en) | Solid textile, method of manufacturing same, and implant employing solid textile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NGUYEN, SON V.;RUPP, KEVIN D.;CHADHA, AJAY;AND OTHERS;SIGNING DATES FROM 20170314 TO 20171024;REEL/FRAME:064581/0240 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |